Enrollme.ru will help to conduct a research at patients with diseases of a system of blood and COVID-19

2020: Providing Enrollme.ru platform

The Энроллми.ру company, the resident Klastera of biomedical technologies of Skolkovo Foundation, provided the technology platform for carrying out in Russia the observation research at patients with diseases of a system of blood and a koronavirusny infection of COVID-19. On June 22, 2020 the Skolkovo Foundation reported about it.

The observation research CHRONOS19 (NCT04422470) is conducted by the National medical research center of hematology (NMITs of hematology) of the Russian Ministry of Health together with several regional hematologic clinics. Also participate in project implementation Fund of support of scientific research in oncology (Rakfond) and the resident Skolkovo - Энроллми.ру company. The technology platform of remote control of the clinical and observation trials "Энроллми.ру" will allow to integrate doctors in the different cities of Russia in a single research network. Within a year work will be able directly to be carried out in "a red zone" in a paperless form and without threat of spread of an infection.

In several recent researches it is revealed that presence of oncological diseases worsens the forecast at patients with a koronavirusny infection of COVID-19. Patients with diseases of a system of blood can have the increased risk of infection with the SARS-CoV-2 virus and heavier course of disease owing to the nature of the main disease and specific treatment which often suppresses immunity. Nevertheless, information on a current of COVID-19 at the patients having hematologic diseases for June, 2020 is limited.

The main objective of the research CHRONOS19 – to define features of a course of a koronavirusny infection of COVID-19 at patients with different hematologic diseases. Specialists hope that the received results will allow to improve methods of treatment of this category of patients in the near future.

This research will combine the efforts of hematologists in several regions of Russia directed to the help to patients with diseases of a system of blood during a pandemic. We need to learn to understand features of an infection at hematologic patients that in the future our patients received the most effective treatment and tactically we were ready to emergence of similar pandemics.

In the period of a pandemic very important not only to learn to control an infection, but also not to miss development of the main disease in hematologic patients. Therefore the huge value has an opportunity to quickly obtain objective data on the course of a disease at especially vulnerable groups of patients to define tactics of maintaining these patients. Results of a research will lay the foundation for improvement of results of treatment of patients with diseases of a system of blood and a koronavirusny infection.

It is obvious that the koronavirusny infection of COVID-19 will remain with people forever. Therefore researchers of the whole world direct the best forces for studying and the analysis of a disease at all groups of patients. Results of a research are very necessary to those people who courageously struggle with other heavy illnesses. We realize importance of this work and are glad to provide the technological solutions for its accomplishment.

Because of a coronavirus pandemic patients with hematologic diseases had risks which are not investigated earlier. Therefore studying of features of a course of the main disease in these conditions becomes one of the most priority tasks for scientists. The electronic platform of the participant proved Skolkovo of Enrollmi.py company and gives the chance to conduct researches completely remotely, eliminating risks of infection of participants of a research.

The research will begin in June, 2020 and about a year will last. About 200 patients with diseases of a system of blood infected with the SARS-CoV-2 virus will take part in it.